These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3171364

  • 1. Surgical management of the discharging mastoid cavity.
    Mills RP.
    J Laryngol Otol Suppl; 1988; 16():1-6. PubMed ID: 3171364
    [Abstract] [Full Text] [Related]

  • 2. Obliteration of the persistently discharging mastoid cavity using the middle temporal artery flap.
    Singh V, Atlas M.
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):433-8. PubMed ID: 17765771
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intraoperative findings in revision canal wall down mastoidectomy.
    Phelan E, Harney M, Burns H.
    Ir Med J; 2008 Jan; 101(1):14. PubMed ID: 18369017
    [Abstract] [Full Text] [Related]

  • 6. Canal wall down tympanoplasty with canal reconstruction for middle-ear cholesteatoma: post-operative hearing, cholesteatoma recurrence, and status of re-aeration of reconstructed middle-ear cavity.
    Ikeda M, Yoshida S, Ikui A, Shigihara S.
    J Laryngol Otol; 2003 Apr; 117(4):249-55. PubMed ID: 12816211
    [Abstract] [Full Text] [Related]

  • 7. [Revision after surgical procedures in the middle ear and mastoid].
    Zelený M, Navrátilová A.
    Cesk Otolaryngol; 1989 Mar; 38(2):78-83. PubMed ID: 2731259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Hong Kong vascularized temporalis fascia flaps for optimal, mastoid cavity reconstruction.
    Van Hasselt CA, Liu KC, Tong MC.
    Rev Laryngol Otol Rhinol (Bord); 1995 Mar; 116(1):57-60. PubMed ID: 7644849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mastoidectomy cavity obliteration with bioactive glass: a pilot study.
    Silvola JT.
    Otolaryngol Head Neck Surg; 2012 Jul; 147(1):119-26. PubMed ID: 22371341
    [Abstract] [Full Text] [Related]

  • 13. Complications with hydroxyapatite cement in mastoid cavity obliteration.
    Ridenour JS, Poe DS, Roberson DW.
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):641-5. PubMed ID: 18984257
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Outcome of bacterial culture from mastoid granulations: is it relevant in chronic ear disease?
    Albert RR, Job A, Kuruvilla G, Joseph R, Brahmadathan KN, John A.
    J Laryngol Otol; 2005 Oct; 119(10):774-8. PubMed ID: 16259653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.